Blastic Plasmacytoid Dendritic Cell Neoplasm: The Dermatologist's Perspective.

Area of Science:

• Hematology
• Oncology
• Dermatology

Background:

• Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare and aggressive hematologic malignancy.
• The neoplasm originates from plasmacytoid dendritic cells and frequently manifests in the skin.

Purpose of the Study:

• To highlight the importance of recognizing BPDCN's cutaneous manifestations.
• To aid dermatologists and oncologists in the early diagnosis of BPDCN.
• To differentiate BPDCN from other skin conditions, such as acute myelogenous leukemia cutis.

Main Methods:

• Review of clinical presentation of BPDCN.
• Analysis of diagnostic challenges in differentiating BPDCN from other cutaneous conditions.

Main Results:

• Cutaneous involvement is a common initial presentation of BPDCN.
• BPDCN skin lesions appear as deep purple to red-brown macules, plaques, or tumors.
• Dermatologists are often the first point of contact for patients with BPDCN.

Conclusions:

• Familiarity with BPDCN's dermatologic presentation is essential for early diagnosis.
• Timely diagnosis by dermatologists can improve patient outcomes by facilitating prompt oncologic consultation and treatment.
• Distinguishing BPDCN from acute myelogenous leukemia cutis is a key diagnostic consideration.